RAD51D
protein-codingRAD51 paralog D
Gene summary
The protein encoded by this gene is a member of the RAD51 protein family. RAD51 family members are highly similar to bacterial RecA and Saccharomyces cerevisiae Rad51, which are known to be involved in the homologous recombination and repair of DNA. This protein forms a complex with several other members of the RAD51 family, including RAD51L1, RAD51L2, and XRCC2. The protein complex formed with this protein has been shown to catalyze homologous pairing between single- and double-stranded DNA, and is thought to play a role in the early stage of recombinational repair of DNA. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream ring finger and FYVE-like domain containing 1 (RFFL) gene. [provided by RefSeq, Jan 2011]
- RAD51L3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~29.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0013669
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0013669
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0003582
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013669
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0700274
Submitter: ClinGen
The protein encoded by RAD51D gene is a member of the RAD51 protein family. The protein complex formed with RAD51D protein has been shown to catalyze homologous pairing between single- and double-stranded DNA and is thought to play a role in the early stage of recombinational repair of DNA. RAD51D has been linked to autosomal dominant RAD51D-related cancer predisposition which includes familial ovarian cancer, triple negative breast cancer and ER negative breast cancer. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism(s) or inheritance pattern among the different cancer predispositions. Therefore, these phenotypes have been lumped into this RAD51D-related cancer predisposition curation. This gene-disease relationship has been studied in at least eight case-control studies at the aggregate variant level. These case-control studies suggested significantly increased risk for ovarian cancer in monoallelic RAD51D variant carriers compared to controls (12 points) (PMIDs: 26261251, 26720728, 30099541, 31341520, 32091585, 33471991, 35084436, 35172496). This gene-disease relationship is also supported by experimental evidence including functional alteration and protein interaction studies (1.5 points; PMIDs: 10749867, 11751635, 27924006). RAD51D-deficient cells had a significantly higher frequency of spontaneous double-strand break. In addition, these cells had a severely reduced capacity for homologous recombination-mediated DNA repair. Yeast two-hybrid and co-immunoprecipitation assays also revealed RAD51D directly interacts with RAD51C and forms a protein complex. In summary, RAD51D is definitively associated with RAD51D-related cancer predisposition (MONDO:0700274). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated as definitive for familial ovarian cancer on 10/11/2017 and as limited for hereditary breast carcinoma on 11/08/2017 by the Breast/Ovarian Cancer GCEP. This lumped re-curation as definitive was approved by the ClinGen Hereditary Cancer GCEP on 03/22/2024 (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0013669
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Oncologic
Intervention: Oncologic
Rationale: Surveillance (similar to that described for individuals with variants in BRCA1 or BRCA2) related to breast or ovarian cancer may allow early diagnosis and treatment of neoplasms (eg, ovarian tumors), which may reduce morbidity and mortality; Specific, targeted therapies may be available
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RAD51D variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002878.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 13 | 339 | 39 | 394 | |
| missense | 5 | 800 | 63 | 3 | 871 | |
| nonsense | 31 | 20 | 8 | 59 | ||
| start loss | 9 | 1 | 10 | |||
| frameshift | 81 | 59 | 10 | 150 | ||
| splice donor/acceptor (+/-2bp) | 6 | 66 | 10 | 82 | ||
| Total | 118 | 162 | 842 | 402 | 42 | 1566 |
Highest pathogenic variant AF is 0.000031598593
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002869.3 | 10 | MANE Select | |
| Ensembl | ENSP00000338790.6 | 10 | MANE Select | |
| RefSeq | NP_001136043.1 | 10 | Standard | |
| RefSeq | NP_598332.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Homologous recombination - Homo sapiens (human)
- TP53 Regulates Transcription of DNA Repair Genes
- HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)
- DNA Repair
- Gene expression (Transcription)
Biological Process
- telomere maintenance
- double-strand break repair via homologous recombination
- DNA repair
- reciprocal meiotic recombination
- interstrand cross-link repair
Molecular Function
- four-way junction DNA binding
- DNA binding
- single-stranded DNA binding
- protein binding
- ATP binding
Cellular Component
- chromosome, telomeric region
- nuclear chromosome, telomeric region
- nucleus
- nucleoplasm
- replication fork
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000590016
- Coding exons
- 10
- Length
- 21731
- Individuals with no LoFs
- 125695
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 53
- Defined
- 125748
- p
- 0.000211
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.112 | 198 | 194 | 1.02 | 0.0000115 | 2194 |
| Missense (PolyPhen) | 60 | 57.789 | 1.0383 | 708 | ||
| Synonymous | -0.0429 | 81 | 80.5 | 1.01 | 0.00000492 | 755 |
| Loss of Function | 0.820 | 16 | 20.0 | 0.802 | 0.00000123 | 199 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00070 | 0.00069 | rare |
| East Asian | 0.00087 | 0.00087 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00017 | 0.00015 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. Bind to single- stranded DNA (ssDNA) and has DNA-dependent ATPase activity. Part of the Rad21 paralog protein complex BCDX2 which acts in the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, BCDX2 acts downstream of BRCA2 recruitment and upstream of RAD51 recruitment. BCDX2 binds predominantly to the intersection of the four duplex arms of the Holliday junction and to junction of replication forks. The BCDX2 complex was originally reported to bind single- stranded DNA, single-stranded gaps in duplex DNA and specifically to nicks in duplex DNA. Involved in telomere maintenance. The BCDX2 subcomplex XRCC2:RAD51D can stimulate Holliday junction resolution by BLM. {ECO:0000269|PubMed:10871607, ECO:0000269|PubMed:11751635, ECO:0000269|PubMed:11834724, ECO:0000269|PubMed:11842113, ECO:0000269|PubMed:12975363, ECO:0000269|PubMed:15109494, ECO:0000269|PubMed:23149936}.;
Intolerance Scores
- RVIS EVS
- 0.53
- RVIS percentile EVS
- 80.96
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- H
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |